Prediction of antiprion activity of therapeutic agents with structure-activity models.

about

Insights from Therapeutic Studies for PrP Prion Disease.In silico strategies on prion pathogenic conversion and inhibition from PrPC -PrPSc.Chemometrics approach for the prediction of structure-activity relationship for membrane transporter bilitranslocase.

P2860

Q39005891-EEFB84F8-EB24-4E52-B8D8-0EC211ACB019 Q39101358-9B42277D-49BF-43BA-99D7-25697F034740 Q46502793-75E6CEC4-D0D7-4CCD-9184-BA5F39478631

P2860

Prediction of antiprion activity of therapeutic agents with structure-activity models.

Item

http://www.wikidata.org/entity/Q43966734

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@en

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@nl

type

Item

label

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@en

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@nl

prefLabel

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@en

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@nl

P1476

Prediction of antiprion activity of therapeutic agents with structure-activity models.

@en

P2093

Katja Venko

http://www.w3.org/2001/XMLSchema#string

Marjana Novič

http://www.w3.org/2001/XMLSchema#string

Špela Župerl

http://www.w3.org/2001/XMLSchema#string

P2860

Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation

Prions

Hot spots in prion protein for pathogenic conversion

Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

NMR Structure of the Human Prion Protein with the Pathological Q212P Mutation Reveals Unique Structural Features

Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation

Assessing the accuracy of prediction algorithms for classification: an overview

Synthesis of monomeric and dimeric acridine compounds as potential therapeutics in Alzheimer and prion diseases.

Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.

P2888

s11030-013-9477-3

P304

133-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11030-013-9477-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256836602

http://www.w3.org/2001/XMLSchema#string

P698

24052197

http://www.w3.org/2001/XMLSchema#string

Prediction of antiprion activity of therapeutic agents with structure-activity models.

about

P2860

P2860

Prediction of antiprion activity of therapeutic agents with structure-activity models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698